These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34847204)

  • 1. The use of heuristics in genetic testing decision-making: A qualitative interview study.
    Zimmermann BM; Shaw DM; Elger B; Koné I
    PLoS One; 2021; 16(11):e0260597. PubMed ID: 34847204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
    Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
    Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncertainty in consultations about genetic testing for cancer: an explorative observational study.
    Medendorp NM; Hillen MA; Murugesu L; Aalfs CM; Stiggelbout AM; Smets EMA
    Patient Educ Couns; 2018 Dec; 101(12):2083-2089. PubMed ID: 30082116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'We don't know for sure': discussion of uncertainty concerning multigene panel testing during initial cancer genetic consultations.
    Medendorp NM; Hillen MA; van Maarschalkerweerd PEA; Aalfs CM; Ausems MGEM; Verhoef S; van der Kolk LE; Berger LPV; Wevers MR; Wagner A; Caanen BAH; Stiggelbout AM; Smets EMA
    Fam Cancer; 2020 Jan; 19(1):65-76. PubMed ID: 31773425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The facilitating role of information provided in genetic counseling for counselees' decisions.
    Shiloh S; Gerad L; Goldman B
    Genet Med; 2006 Feb; 8(2):116-24. PubMed ID: 16481895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: an explorative assessment.
    Vos J; Menko FH; Oosterwijk JC; van Asperen CJ; Stiggelbout AM; Tibben A
    Psychooncology; 2013 May; 22(5):1167-76. PubMed ID: 22777929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the short-term impact of DNA-testing in breast cancer patients: the counselees' perception matters, but the actual BRCA1/2 result does not.
    Vos J; Oosterwijk JC; Gomez-Garcia E; Menko FH; Collee MJ; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
    Patient Educ Couns; 2012 Feb; 86(2):239-51. PubMed ID: 21684708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of counselee and counselor satisfaction in reproductive genetic counseling.
    Aalfs CM; Oort FJ; de Haes JC; Leschot NJ; Smets EM
    Clin Genet; 2007 Aug; 72(2):74-82. PubMed ID: 17661810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges to effective and autonomous genetic testing and counseling for ethno-cultural minorities: a qualitative study.
    Cohen-Kfir N; Bentwich ME; Kent A; Dickman N; Tanus M; Higazi B; Kalfon L; Rudolf M; Falik-Zaccai TC
    BMC Med Ethics; 2020 Oct; 21(1):98. PubMed ID: 33059675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What information do cancer genetic counselees prioritize?
    Hayat Roshanai A; Lampic C; Ingvoldstad C; Askmalm MS; Bjorvatn C; Rosenquist R; Nordin K
    J Genet Couns; 2012 Aug; 21(4):510-26. PubMed ID: 21993709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision making and experiences of young adults undergoing presymptomatic genetic testing for familial cancer: a longitudinal grounded theory study.
    Godino L; Jackson L; Turchetti D; Hennessy C; Skirton H
    Eur J Hum Genet; 2018 Jan; 26(1):44-53. PubMed ID: 29162934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying hereditary cancer: genetic counseling and cancer risk assessment.
    Lewis KM
    Curr Probl Cancer; 2014; 38(6):216-25. PubMed ID: 25432528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Factors for Distress After Genetic Testing for Hereditary Cancer.
    Voorwinden JS; Jaspers JP
    J Genet Couns; 2016 Jun; 25(3):495-503. PubMed ID: 26475052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncertainty related to multigene panel testing for cancer: a qualitative study on counsellors' and counselees' views.
    Medendorp NM; Hillen MA; Murugesu L; Aalfs CM; Stiggelbout AM; Smets EMA
    J Community Genet; 2019 Apr; 10(2):303-312. PubMed ID: 30430454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial cancer genetic counseling consultation: change in counselees' cognitions and anxiety, and association with addressing their needs and preferences.
    Pieterse AH; Ausems MG; Van Dulmen AM; Beemer FA; Bensing JM
    Am J Med Genet A; 2005 Aug; 137(1):27-35. PubMed ID: 16007615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
    Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
    J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "I have always lived with the disease in the family": family adaptation to hereditary cancer-risk.
    Silva E; Gomes P; Matos PM; Silva ER; Silva J; Brandão C; Castro F; Neves MC; Sales CMD
    BMC Prim Care; 2022 Apr; 23(1):93. PubMed ID: 35461227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the preferences of involved health professionals regarding the implementation of an online decision aid to support couples during reproductive decision-making in hereditary cancer: a mixed methods approach.
    Reumkens K; de Die-Smulders CEM; van Osch LADM
    Fam Cancer; 2019 Apr; 18(2):285-291. PubMed ID: 30656480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
    Lerman C; Biesecker B; Benkendorf JL; Kerner J; Gomez-Caminero A; Hughes C; Reed MM
    J Natl Cancer Inst; 1997 Jan; 89(2):148-57. PubMed ID: 8998184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How patients deal with an ambiguous medical test: Decision-making after genetic testing.
    Scherr CL; Ramesh S; Getachew-Smith H; Kalke K; Ramsey K; Fischhoff B; Vadaparampil ST
    Patient Educ Couns; 2021 May; 104(5):953-959. PubMed ID: 33214013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.